Miglustat

Miglustat
Product Description

Miglustat is a rare drug used majorly for the treatment of Gaucher's disease, (a condition in which a certain fatty substance is not broken down normally in the body and instead builds up in some organs and causes liver, spleen, bone, and blood problems). Miglustat is in a class of medications called enzyme inhibitors. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea.

US DMF filing planned in Q4 2021. product manufactured in a US FDA approved facility. 


Available form: API
Planned : Capsules

Apothecon Pharmaceuticals

  • IN
  • 2018
    On CPHI since
Specifications
  • CAS Registry Number
    72599-27-0
  • Supplied from
    India

Apothecon Pharmaceuticals

  • IN
  • 2018
    On CPHI since

More Products from Apothecon Pharmaceuticals (23)

  • Cyclophosphamide Monohydrate

    Product Cyclophosphamide Monohydrate

    A niche oncology API used for the treatment of malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma. multiple myeloma.. Available for all global markets ex...
  • Melphalan HCl

    Product Melphalan HCl

    A niche oncology API used for the treatment of multiple myeloma and ovarian cancer. Melphalan HCl Injection, at high intravenous dosage, is indicated, with or without haematopoietic stem cell transplantation, for the treatment of multiple myeloma and childhood neuroblastoma. Available for all global mar...
  • Sevelamer Carbonate

    Product Sevelamer Carbonate

    A niche API used in its finished form (tablet) for the treatment of hyperphosphatemia in patients with chronic kidney disease. Available for all global markets along with DMF support.

  • Sevelamer Hydrochloride

    Product Sevelamer Hydrochloride

    A niche API used in its finished form (tablet) for the treatment of hyperphosphatemia in patients with chronic kidney disease. Available for all global markets along with DMF support.

  • Trientine Hydrochloride

    Product Trientine Hydrochloride

    An orphan drug API is used in its finished form (capsules) for the treatment of the rare occurring Wilson’s disease. Available for select markets along with DMF support.

  • Ferric Carboxy Maltose

    Product Ferric Carboxy Maltose

    Ferric carboxymaltose (Ferinject(R)), a novel iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of iron to target tissues. Administered intravenously, it is effective in the treatment of iron-deficiency anaemia, delivering a replenishme...
  • Carmustine

    Product Carmustine

    A niche oncology API used in its finished form (injectable) for the treatment of brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. Available for all global markets except the US along with DMF support.

  • Fomepizole

    Product Fomepizole

    An orphan drug API used in its finished form (injectable) is the only known antidote for methanol and ethylene glycol poisoning in the world. Available for all global markets along with DMF support.

  • Fosaprepitant Dimeglumine

    Product Fosaprepitant Dimeglumine

    A niche API used in its finished form (injectable) in adults and children to prevent nausea and vomiting caused by cancer chemotherapy. Available for all global markets along with DMF support.

  • Ropivacaine (base)

    Product Ropivacaine (base)

    A niche API used in its finished form (injectable) for production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures Available for all global markets along with DMF support.

  • Ropivacaine Hydrochloride

    Product Ropivacaine Hydrochloride

    A niche API used in its finished form (injectable) to administer local anesthesia, regional anesthesia, or surgical anesthesia.. Available for all global markets along with DMF support.

  • Benztropine Mesylate

    Product Benztropine Mesylate

    A niche API used in its finished form (tablet and injectable) for the treatment of parkinsonism or Parkinson's disease, including tremor due to the disease, drug-induced extrapyramidal symptoms and chronic sialorrhea (chronic drooling) in developmentally-disabled patients. Available for all global market...